middle.news
Clarity Pharmaceuticals Unveils Superior Prostate Cancer Imaging and Therapy Data
9:57am on Thursday 6th of August, 2026 AEST
•
Healthcare
Read Story
Clarity Pharmaceuticals Unveils Superior Prostate Cancer Imaging and Therapy Data
9:57am on Thursday 6th of August, 2026 AEST
Key Points
64Cu-SAR-bisPSMA detects more lesions than FDA-approved PSMA PET agents
Next-day imaging boosts lesion visibility and diagnostic confidence
67Cu-SAR-bisPSMA shows promising safety and efficacy in advanced prostate cancer
Multiple Phase III trials underway to support regulatory approvals
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clarity Pharmaceuticals (ASX:CU6)
OPEN ARTICLE